Prabhat Tomar

I am a dedicated scientist with a proven track record at Oregon State University and The Hebrew University of Jerusalem, specializing in biotechnology and protein biochemistry. Expert in assay development and high-throughput screening, with a flair for mentorship. Demonstrated success in innovative drug discovery projects, enhancing research methodologies, and publishing influential papers.

E protein channel blockers and ORF 3 inhibitors as Anti-Covid-19 Agents, Arkin I.T., Tomar P.P.S., Krugliak M., US20230190769A1, 2022, https://patents.google.com/patent/US20230190769A1/en

• Selected among the top 20 in India for 'Biotechnology Entrepreneurship Student Teams', Department of Biotechnology, Ministry of Science and Technology, Government of India, 07/01/11
• Qualified National level CSIR-NET Exam for Ph.D. fellowship, 06/01/08
• Qualified National level ICMR-JRF Exam for project fellowship, 07/01/07

• Zika M - A Potential Viroporin: Mutational Study and Drug Repurposing, Tomar, P. P. S., Krugliak, M., Singh A., & Arkin, I. T., 2022, Biomedicines, 10, 3, 641
• Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library, Tomar, P. P. S., Krugliak, M., & Arkin, I. T., 2021, Pharmaceuticals, 14, 7, 604
• Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing, Tomar, P. P. S., Krugliak, M., & Arkin, I. T., 2021, Viruses, 13, 3, 532
• SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine, Tomar, P. P. S., & Arkin, I. T., 2020, Biochemical and Biophysical Research Communications, 530, 1, 10-14, 134
• Potential viroporin candidates from pathogenic viruses using bacteria-based bioassays, Tomar, P. P. S., Oren, R., Krugliak, M., & Arkin, I. T., 2019, Viruses, 11, 7, 632, 19
• Characterization of a bacterioferritin comigratory protein family 1-Cys peroxiredoxin from Candidatus Liberibacter asiaticus, Singh, A., Kumar, N., Tomar, P. P. S., Bhose, S., Ghosh, D. K., Roy, P., & Sharma, A. K., 2017, Protoplasma, 254, 4, 1675-1691, 17
• Characterization and cloning of an 11S globulin with hemagglutination activity from Murraya paniculata, Singh, A., Selvakumar, P., Saraswat, A., Tomar, P. P. S., Mishra, M., K Singh, P., & K Sharma, A., 2015, Protein and Peptide Letters, 22, 8, 750-761, 5
• Purification, characterization, and cloning of a 2S albumin with DNase, RNase, and antifungal activities from Putranjiva roxburghii, Tomar, P. P. S., Chaudhary, N. S., Mishra, P., Gahloth, D., Patel, G. K., Selvakumar, P., ... & Sharma, A. K., 2014, Applied Biochemistry and Biotechnology, 174, 2, 471-482, 24
• Characterization of anticancer, DNase and antifungal activity of pumpkin 2S albumin, Tomar, P. P. S., Nikhil, K., Singh, A., Selvakumar, P., Roy, P., & Sharma, A. K., 2014, Biochemical and Biophysical Research Communications, 448, 4, 349-354, 49
• Structural insights into the aggregation behavior of Murraya koenigii miraculin-like protein below pH 7.5, Selvakumar, P., Sharma, N., Tomar, P. P. S., Kumar, P., & Sharma, A. K., 2014, Proteins: Structure, Function, and Bioinformatics, 82, 5, 830-840
• Molecular evolution of miraculin-like proteins in soybean Kunitz superfamily, Selvakumar, P., Gahloth, D., Tomar, P. P. S., Sharma, N., & Sharma, A. K., 2011, Journal of Molecular Evolution, 73, 5-6, 369-379, 27

• Prof. Isaiah T. Arkin, Ph.D., Professor, Department of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Jerusalem, 91904, Israel, (972)-(0)2-658-4329, arkin@savion.huji.ac.il, arkin@huji.ac.il
• Prof. Ashwani Kumar Sharma, Professor, Department of Bioscience and Bioengineering, Indian Institute of Technology-Roorkee, Roorkee, Uttarakhand, India, 91-1332-285657, ashwani.sharma@bt.iitr.ac.in
• Prof. Pravindra Kumar, Professor, Department of Bioscience and Bioengineering, Indian Institute of Technology-Roorkee, Roorkee, Uttarakhand, India, 91-1332-285072, pravindra.kumar@bt.iitr.ac.in

• DNA in Droplets: Synthetic biology on a novel digital microfluidics device (DMF), Oregon bioengineering symposium (OBS 2023), Eugene, Oregon, USA, 11/03/23
• Characterization of SARS-CoV-2 proteins as viroporins via bacterial assay and targeted drug repurposing, Volcano Conference in Chemical Biology (VCCB) 2023, Seattle, Washington, USA
• Identification of new viroporin candidates from pathogenic viruses using bacteria-based bioassays, ILANIT/FISEB conference, Eilat, Israel, Israel, 02/17/20 - 02/20/20
• INDO-US international conference/ workshop on recent advances in structural biology & drug discovery, IIT Roorkee, Roorkee, Uttarakhand, India, 10/09/14 - 10/11/14
• 42nd National Seminar on Crystallography and International workshop on the application of X-ray diffraction for drug discovery, New Delhi, Delhi, India
• 7th Asian Biophysics Association Symposium and Annual Meetings of the Indian Biophysical Society, New Delhi, Delhi, India, 01/30/11 - 02/02/11
• XXXIX National Seminar on Crystallography, Jammu, Jammu and Kashmir, India, 10/25/10 - 10/27/10

• Recognized among the top 20 in India for ‘Biotechnology Entrepreneurship Student Teams’ sponsored by the Department of Biotechnology, Ministry of Science and Technology, Government of India, July 2011
• Qualified for Ph.D. Fellowship through the Council of Scientific and Industrial Research (CSIR) National Eligibility Test (NET), June 2008
• Qualified for the Indian Council of Medical Research (ICMR) Junior Research Fellowship (JRF) Exam, July 2007

• English
• Hindi

• Date of Birth: 01/01/84
• Gender: Male
• Nationality: Indian
• Marital Status: Married

• I currently hold a J-2 visa with valid work authorization (EAD) until June 30, 2025. Sponsorship will be required to continue employment beyond this date.